Fetuin-A (α-2-Heremans-Schmid glycoprotein, FETUA-AHSG), independent of the infection phase in which the plasma was collected, has been shown to represent a key molecule for classifying patients based on the outcome. This evidence concerns the gene AHSG and infection.